PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy

Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1107
https://www.valueinhealthjournal.com/article/S1098-3015(11)02669-6/fulltext
Section Title : Cancer
Section Order : 1066
First Page : A434
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02669-6&doi=10.1016/j.jval.2011.08.1107
HEOR Topics :
Tags :
Regions :